HIPAA-compliant · Same-day admissions available
Robin Campbell, LMFT, PHD Meth and cocaine addiction can be difficult to treat because there are no FDA-approved medications specifically.
Maverick
Clinical Editorial Team
Meth and cocaine addiction can be difficult to treat because there are no FDA-approved medications specifically for stimulant use disorder. As rising rates of stimulant use, polysubstance use, and overdose continue to affect communities across Tennessee, treatment providers are looking for more effective treatment approaches that help people stay engaged in care. One approach gaining attention is contingency management for stimulant use disorder, but many people are unfamiliar with how it works or why contingency management programs are being used in addiction treatment settings.
Contingency management for stimulant use disorder is a treatment approach that rewards positive recovery steps. A person may earn rewards for attending treatment, meeting recovery goals, or having negative drug tests. These programs commonly run 12 to 24 weeks, with each target behavior tied to a clear incentive plan. This can help people with meth or cocaine addiction stay engaged when cravings, low mood, or fatigue make recovery hard, especially when incentives are most effective through prompt, frequent delivery. Contingency management works best as part of a larger treatment plan. In an IOP, it may be used with therapy, relapse prevention, group support, and care for co-occurring mental health symptoms.
Meth and cocaine addiction can change reward, motivation, and decision-making. As use continues, many people struggle to control cravings, stop using, or avoid triggers. This pattern can affect work, school, finances, relationships, and physical health.
Structured treatment helps people build stability during recovery. An intensive outpatient program (IOP) can provide therapy, relapse prevention education, accountability, and support while a person continues living at home.
Stimulant use disorder often affects energy, reward, focus, sleep, and mood. Meth and cocaine can create intense bursts of alertness and confidence, followed by a crash that may include fatigue, depression, anxiety, and strong cravings. Many people also experience binge-use patterns, where they use repeatedly over hours or days and then crash after the drug wears off. Opioid addiction often carries a high overdose risk because opioids can slow or stop breathing. Alcohol addiction can involve dangerous withdrawal symptoms, including seizures or delirium tremens. Stimulant addiction is different because it often brings severe sleep loss, paranoia, aggression, psychosis, heart strain, and impulsive behavior that can disrupt daily life quickly.
There is no FDA-approved medication that treats stimulant use disorder directly. This means there is no medication option like buprenorphine for opioid use disorder or acamprosate for alcohol use disorder.
Because of this, treatment often uses contingency management, therapy, drug testing, group support, and relapse prevention. These tools help people reduce drug use, manage cravings, and stay engaged in outpatient care. In practice, contingency management is usually used alongside other treatments such as therapy, group support, drug testing, and relapse prevention rather than on its own.
Stimulants such as methamphetamine and cocaine increase levels of dopamine and other brain chemicals linked to pleasure, energy, attention, and motivation. This can create feelings of euphoria, confidence, alertness, and increased activity. As the effects wear off, people may experience a crash that includes fatigue, depression, irritability, and intense cravings.
Repeated stimulant use can place significant stress on both the brain and body. Long-term use may affect memory, concentration, emotional regulation, sleep patterns, and decision-making. Physical effects can include heart problems, high blood pressure, weight loss, dental issues, and an increased risk of stroke or other medical complications.
Stimulant use disorder often affects much more than physical health. Many people experience difficulties maintaining employment due to missed work, poor performance, attendance issues, or conflicts with supervisors and coworkers. Financial problems may develop as more time and money are spent obtaining and using drugs. Relationships frequently suffer as stimulant use becomes a priority. Family members may lose trust after repeated dishonesty, broken promises, or unpredictable behavior. Some individuals also face legal consequences, including arrests, probation violations, drug possession charges, driving offenses, or child custody concerns related to substance use.
Stimulant use remains a serious issue in Tennessee, especially when methamphetamine and cocaine appear with fentanyl, synthetic opioids, alcohol, benzodiazepines, or other drugs. Tennessee’s 2024 overdose report shows that fentanyl and other synthetic opioids were involved in more overdose deaths than any other drug, and methamphetamine continued to be a major substance involved in overdose deaths. Knox County reporting also listed synthetic opioids, cocaine, xylazine, and methamphetamine among common drugs involved in overdose deaths. This overdose crisis has also pushed policymakers to consider opioid settlement funds to support contingency management for stimulant use disorder and better address stimulant harms.
Short-Term:
Long-Term:
Many people with stimulant use disorder also live with anxiety disorders, major depressive disorder, post-traumatic stress disorder (PTSD), bipolar disorder, attention-deficit/hyperactivity disorder (ADHD), or other mental health conditions. Some people begin using meth or cocaine to increase energy, improve focus, cope with stress, or escape difficult emotions. Over time, stimulant use can worsen mental health symptoms and make recovery more challenging. Co-occurring disorders often increase the risk of relapse when both conditions are not treated together. Integrated treatment can help people address substance use, emotional symptoms, coping skills, and recovery goals at the same time. Treating both conditions together is associated with better long-term outcomes.
Stimulant withdrawal is often different from opioid or alcohol withdrawal. While it is usually not life-threatening, it can bring intense fatigue, depression, irritability, anxiety, sleep problems, increased appetite, and strong cravings. Many people feel emotionally and physically drained during the first days or weeks after stopping use. These symptoms can make it difficult to stay motivated in recovery. Cravings and low mood often increase the risk of returning to drug use. Structured treatment, therapy, and contingency management can help people stay engaged during this challenging period.
Contingency management uses rewards to support treatment attendance, recovery goals, and negative drug tests. Drug testing helps measure progress, and the target behavior is usually clear, such as consistent attendance or stimulant-free results. Many CM programs use an escalating reward structure, but a positive drug test may return the patient to the starting level. Research from the Mental Health Services Administration, Veterans Affairs, university studies, and the Motivational Incentives Policy Group shows robust evidence that CM pilot programs can support substance use disorders, medication adherence, treatment participation, and implementation support across several states, State Opioid Response funding, treatment services, and substance abuse treatment programs. Many treatment programs receive implementation support from a range of state and university partners to help centers implement contingency management effectively.
Stimulant use affects the brain’s reward system, making drug use feel highly reinforcing. Contingency management helps create new connections between healthy behaviors and positive outcomes. Rewards can motivate people to continue attending treatment and working toward recovery goals. Over time, these positive habits may become more rewarding on their own. As recovery progresses, people often begin to experience benefits such as improved relationships, better health, financial stability, and increased confidence.
An intensive outpatient program (IOP) provides a structured level of care without requiring an overnight stay. Participants attend treatment several days each week while continuing to live at home and manage daily responsibilities. This allows people to receive support while maintaining work, school, or family commitments.
IOP often includes individual therapy, group counseling, relapse prevention education, drug testing, family involvement, and treatment for co-occurring mental health conditions. For many people with stimulant use disorder, IOP provides the balance of flexibility and accountability needed for recovery.
Family support can play an important role in recovery from meth or cocaine addiction. Loved ones often provide encouragement, accountability, transportation, emotional support, and help during difficult periods of treatment. Healthy family involvement may also improve communication and rebuild trust damaged by substance use. Families can benefit from learning about addiction, boundaries, relapse warning signs, and recovery expectations. Education helps loved ones support recovery without enabling substance use. Strong support systems are often linked to better treatment outcomes.
Seek help when meth or cocaine use causes cravings, paranoia, sleep loss, depression, money problems, work issues, relationship strain, or failed attempts to quit. Help is also needed when stimulant use leads to risky behavior, legal problems, or worsening mental health symptoms.
Many insurance plans cover stimulant use disorder treatment when care is medically necessary. Coverage for CM may depend on policy, Medicaid services, waivers, federal funds, and authorization rules. SAMHSA raised the incentive cap from a $75 annual limit to $750 per year, though implementation through Medicaid waivers can still take time. Coverage may include IOP, PHP, therapy, drug testing, group counseling, family support, and mental health services.
Contingency management treatment has strong research support and continues to show promise for treating individuals with stimulant use disorder. Studies, systematic review findings, meta analysis data, and federal initiatives have highlighted the effectiveness of CM interventions in improving treatment retention, treatment adherence, and other positive recovery behaviors. Whether used in IOP, PHP, or other treatment settings, contingency management can be an important part of a recovery plan that helps people reduce stimulant use and build long-term recovery skills.
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial. Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being. Effective medication management is a crucial part of the treatment process to ensure safety and success. Give us a call at 866-799-0806.
Visit SAMHSA for more information.
It uses rewards to support sobriety, treatment attendance, and negative drug tests.
Yes. It is one of the strongest evidence-based treatments for stimulant use disorder.
Yes. IOP can pair rewards with therapy, drug testing, and relapse prevention.
No FDA-approved medication exists. Behavioral treatment is the main approach.
Rewards reinforce sober choices and help rebuild motivation.
Seek help when stimulant use causes cravings, paranoia, sleep loss, money issues, or failed attempts to quit.
](https://library.samhsa.gov/sites/default/files/contingency-management-advisory-pep24-06-001.pdf)
](https://library.samhsa.gov/sites/default/files/pep20-06-01-001.pdf)
](https://www.ncbi.nlm.nih.gov/books/NBK606626/)
](https://www.mentalhealth.va.gov/substance-use/stimulants.asp)
](https://www.kff.org/medicaid/section-1115-waiver-watch-a-look-at-the-use-of-contingency-management-to-address-stimulant-use-disorder/)
In This Article
Tags
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Many parents are concerned about youth vaping, especially as vaping devices, e cigarettes, marijuana products,.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Alcohol use disorder affects people from all backgrounds and can range from risky drinking patterns to severe alcohol.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Teen vaping has become a growing concern for families across Knox County.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Opioid addiction can affect health, work, family, and daily life.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD A benzo taper can be an important part of recovery for people who have become dependent on Xanax, Klonopin, Ativan,.
Clinically Reviewed by: Dr. Robin Campbell, LMFT, PHD Xylazine, a veterinary tranquilizer, is increasingly being found alongside fentanyl and other drugs in the illicit.
New Hope Healthcare Institute offers confidential admissions support for addiction and mental health care—adults and teens—in Knoxville. Call or text 24/7. Verification is not a guarantee of coverage or admission.
